8-K Announcements
6Material company update
May 22, 2026·SEC
Material company update
May 6, 2026·SEC
Material company update
Feb 26, 2026·SEC
MannKind Corporation(MNKD)Earnings, Financials & Key Ratios
MNKD•NASDAQ
197.0× P/E·Price updated Jun 19, 2026
AboutMannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.Show more
- Revenue$349M+22.2%
- EBITDA$51M-37.4%
- Net Income$6M-78.7%
- EPS (Diluted)0.02-79.4%
- Gross Margin82.47%+12.7%
- EBITDA Margin14.64%-48.8%
- Operating Margin11.12%-56.3%
- Net Margin1.68%-82.6%
MNKD Key Insights
MannKind Corporation (MNKD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 39.9%
✗Weaknesses
- ✗Shares diluted 10.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when MNKD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MNKD Price & Volume
MannKind Corporation (MNKD) stock price & volume — 10-year historical chart
Loading chart...
MNKD Growth Metrics
MannKind Corporation (MNKD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years39.89%
3 Years51.8%
TTM21.23%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-179.41%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-175.43%
Return on Capital
10 Years-220%
5 Years-4.74%
3 Years10.82%
Last Year8.32%
MNKD Recent Earnings
MannKind Corporation (MNKD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (45%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.05-150.0%
$0.02
Rev
$90M-14.4%
$105M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.05-400.0%
$0.01
Rev
$112M+14.7%
$98M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.03+200.0%
$0.01
Rev
$82M-17.7%
$100M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.00-94.7%
$0.04
Rev
$77M-4.5%
$80M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.05vs $0.02-150.0% | $90Mvs $105M-14.4% |
| Q1 2026 | Feb 26, 2026 | $0.05vs $0.01-400.0% | $112Mvs $98M+14.7% |
| Q4 2025 | Nov 5, 2025 | $0.03vs $0.01+200.0% | $82Mvs $100M-17.7% |
| Q3 2025 | Aug 6, 2025 | $0.00vs $0.04-94.7% | $77Mvs $80M-4.5% |
Based on last 12 quarters of dataView full earnings history →
MNKD Peer Comparison
MannKind Corporation (MNKD) competitors in Metabolic and Obesity Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 UTHR | 22.78B | 536.59 | 19.26 | 10.61% | 40.61% | 19.24% | ||
 INSM | 20.76B | 95.80 | -14.95 | 66.73% | -144.44% | -130.11% | 1.04 | |
 ACAD | 3.7B | 21.62 | 9.44 | 11.87% | 34.3% | 35.65% | 0.04 | |
 PTCT | 6.55B | 78.98 | 10.15 | 114.51% | -22.58% | |||
 RARE | 2.7B | 27.44 | -4.71 | 20.13% | -91.03% | -6.08% | ||
 NVO | 191.93B | 43.19 | 12.18 | 6.43% | 37.2% | 66.36% | 0.67 | |
 SNY | 102.35B | 42.38 | 18.14 | 5.49% | 16.72% | 10.78% | 0.30 | |
 LLY | 1.04T | 1098.13 | 47.85 | 44.7% | 34.98% | 101.17% | 1.60 |
Compare MNKD vs Peers
MannKind Corporation (MNKD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MNKD Income Statement
MannKind Corporation (MNKD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 11.74M | 27.86M | 63.04M | 65.14M | 75.44M | 99.77M | 198.96M | 285.5M | 348.97M | 360.78M |
Revenue Growth % | -93.28% | 137.2% | 126.28% | 3.34% | 15.81% | 32.25% | 99.42% | 43.5% | 22.23% | 21.23% |
Cost of Goods Sold | 17.23M | 20.48M | 27.98M | 24.64M | 38.86M | 57.5M | 62.77M | 76.6M | 61.16M | 86.73M |
COGS % of Revenue | 146.68% | 73.51% | 44.38% | 37.83% | 51.51% | 57.63% | 31.55% | 26.83% | 17.53% | - |
Gross Profit | -5.48M▲ 0% | 7.38M▲ 234.6% | 35.06M▲ 375.1% | 40.5M▲ 15.5% | 36.59M▼ 9.7% | 42.27M▲ 15.5% | 136.19M▲ 222.2% | 208.9M▲ 53.4% | 287.81M▲ 37.8% | 274.05M▲ 0% |
Gross Margin % | -46.68% | 26.49% | 55.62% | 62.17% | 48.49% | 42.37% | 68.45% | 73.17% | 82.47% | 75.96% |
Gross Profit Growth % | -104.4% | 234.6% | 375.05% | 15.53% | -9.67% | 15.55% | 222.17% | 53.39% | 37.77% | - |
Operating Expenses | 88.86M | 88.44M | 79.66M | 88.42M | 83.61M | 106.38M | 127.51M | 136.31M | 249M | 260.65M |
OpEx % of Revenue | 756.59% | 317.47% | 126.36% | 135.72% | 110.82% | 106.63% | 64.09% | 47.75% | 71.36% | - |
Selling, General & Admin | 74.96M | 79.72M | 74.67M | 59.04M | 77.42M | 91.47M | 94.31M | 94.33M | 144.13M | 173.21M |
SG&A % of Revenue | 638.22% | 286.14% | 118.45% | 90.63% | 102.62% | 91.68% | 47.4% | 33.04% | 41.3% | - |
Research & Development | 14.12M | 8.74M | 6.9M | 6.25M | 12.31M | 19.72M | 31.28M | 45.89M | 66.35M | 72.56M |
R&D % of Revenue | 120.2% | 31.36% | 10.95% | 9.59% | 16.32% | 19.77% | 15.72% | 16.07% | 19.01% | - |
Other Operating Expenses | 13K | -437K | -1.91M | 23.13M | -6.12M | -4.81M | 1.92M | -3.91M | 38.52M | 2M |
Operating Income | -108.19M▲ 0% | -76.59M▲ 29.2% | -44.6M▲ 41.8% | -47.91M▼ 7.4% | -47.02M▲ 1.9% | -64.11M▼ 36.3% | 8.68M▲ 113.5% | 72.59M▲ 736.4% | 38.8M▼ 46.5% | 13.4M▲ 0% |
Operating Margin % | -921.15% | -274.94% | -70.75% | -73.55% | -62.33% | -64.26% | 4.36% | 25.42% | 11.12% | 3.72% |
Operating Income Growth % | -260.85% | 29.2% | 41.78% | -7.44% | 1.86% | -36.34% | 113.54% | 736.45% | -46.55% | - |
EBITDA | -106.39M | -74.89M | -42.44M | -44.59M | -43.78M | -57.8M | 13.21M | 81.56M | 51.09M | 30.42M |
EBITDA Margin % | -905.82% | -268.84% | -67.33% | -68.44% | -58.03% | -57.93% | 6.64% | 28.57% | 14.64% | 8.43% |
EBITDA Growth % | -252.73% | 29.6% | 43.33% | -5.05% | 1.81% | -32.03% | 122.86% | 517.23% | -37.36% | -65.49% |
D&A (Non-Cash Add-back) | 1.8M | 1.7M | 2.15M | 3.33M | 3.24M | 6.31M | 4.54M | 8.97M | 12.28M | 17.02M |
EBIT | -104.01M | -77.3M | -41M | -47.99M | -64.35M | -62.63M | 10.59M | 68.5M | 15.24M | 11.48M |
Net Interest Income | -12.98M | -8.94M | -9.91M | -9.3M | -16.46M | -22.26M | -19.01M | -25.37M | -13.83M | -29.43M |
Interest Income | 293K | 501K | 997K | 167K | 112K | 2.51M | 6.15M | 12.62M | 0 | 9.68M |
Interest Expense | 13.28M | 9.44M | 10.91M | 9.47M | 16.58M | 24.77M | 25.16M | 37.98M | 13.83M | 39.11M |
Other Income/Expense | -9.09M | -10.14M | -7.31M | -9.54M | -33.9M | -23.29M | -19.05M | -42.07M | -37.39M | -41.98M |
Pretax Income | -117.28M▲ 0% | -86.73M▲ 26.0% | -51.9M▲ 40.2% | -57.46M▼ 10.7% | -80.93M▼ 40.8% | -87.4M▼ 8.0% | -10.38M▲ 88.1% | 30.52M▲ 394.1% | 1.41M▼ 95.4% | -28.58M▲ 0% |
Pretax Margin % | -998.57% | -311.34% | -82.34% | -88.2% | -107.27% | -87.6% | -5.22% | 10.69% | 0.4% | -7.92% |
Income Tax | 51K | 240K | 0 | -218K | 0 | 0 | 1.56M | 2.93M | -4.46M | -4.66M |
Effective Tax Rate % | -0.04% | -0.28% | 0% | 0.38% | 0% | 0% | -15.04% | 9.6% | -316.7% | 16.31% |
Net Income | -117.33M▲ 0% | -86.97M▲ 25.9% | -51.9M▲ 40.3% | -57.24M▼ 10.3% | -80.93M▼ 41.4% | -87.4M▼ 8.0% | -11.94M▲ 86.3% | 27.59M▲ 331.1% | 5.86M▼ 78.7% | -23.91M▲ 0% |
Net Margin % | -999% | -312.2% | -82.34% | -87.87% | -107.27% | -87.6% | -6% | 9.66% | 1.68% | -6.63% |
Net Income Growth % | -193.37% | 25.87% | 40.32% | -10.28% | -41.38% | -8% | 86.34% | 331.09% | -78.75% | -179.41% |
Net Income (Continuing) | -117.33M | -86.97M | -51.9M | -57.24M | -80.93M | -87.4M | -11.94M | 27.59M | 5.86M | -23.91M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.13▲ 0% | -0.60▲ 46.9% | -0.31▲ 48.3% | -0.26▲ 16.1% | -0.37▼ 42.3% | -0.44▼ 18.9% | -0.04▲ 89.8% | 0.10▲ 317.4% | 0.02▼ 79.4% | -0.08▲ 0% |
EPS Growth % | -183.09% | 46.9% | 48.33% | 16.13% | -42.31% | -18.92% | 89.84% | 317.45% | -79.42% | -175.43% |
EPS (Basic) | -1.13 | -0.60 | -0.31 | -0.26 | -0.37 | -0.44 | -0.04 | 0.10 | 0.02 | - |
Diluted Shares Outstanding | 104.25M | 144.14M | 195.58M | 222.59M | 249.24M | 257.09M | 267.01M | 283.84M | 314.11M | 308.27M |
Basic Shares Outstanding | 103.83M | 144.14M | 195.58M | 222.59M | 249.24M | 257.09M | 267.01M | 274.42M | 305.64M | 308.27M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
MNKD Balance Sheet
MannKind Corporation (MNKD) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 57.22M | 81.85M | 60.76M | 79.48M | 219.49M | 234.9M | 373.39M | 268.31M | 291.58M | 251.16M |
Cash & Short-Term Investments | 43.95M | 71.16M | 49.88M | 67M | 204.12M | 170.85M | 295.1M | 197.26M | 171.35M | 133.86M |
Cash Only | 43.95M | 71.16M | 29.91M | 67M | 124.18M | 69.77M | 238.48M | 46.34M | 74.88M | 52.83M |
Short-Term Investments | 0 | 0 | 19.98M | 0 | 79.93M | 101.08M | 56.62M | 150.92M | 96.46M | 81.03M |
Accounts Receivable | 2.79M | 4.02M | 3.51M | 4.22M | 4.74M | 16.8M | 14.9M | 11.8M | 38.37M | 28.74M |
Days Sales Outstanding | 86.67 | 52.63 | 20.34 | 23.63 | 22.93 | 61.47 | 27.34 | 15.09 | 40.13 | 28.61 |
Inventory | 2.66M | 3.6M | 4.16M | 4.97M | 7.15M | 21.77M | 28.55M | 27.89M | 35.31M | 49.17M |
Days Inventory Outstanding | 56.29 | 64.11 | 54.2 | 73.66 | 67.18 | 138.21 | 165.98 | 132.87 | 210.75 | 147.23 |
Other Current Assets | 5.21M | 527K | 316K | 158K | 0 | 25.48M | 34.85M | 31.36M | 46.55M | 39.4M |
Total Non-Current Assets | 27.36M | 25.85M | 32.97M | 29.13M | 101.67M | 60.39M | 101.81M | 125.54M | 500.6M | 493.24M |
Property, Plant & Equipment | 26.92M | 25.6M | 26.78M | 25.87M | 36.61M | 45.13M | 84.22M | 85.36M | 82.42M | 93.84M |
Fixed Asset Turnover | 0.44x | 1.09x | 2.35x | 2.52x | 2.06x | 2.21x | 2.36x | 3.34x | 4.23x | 4.09x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 2.43M | 1.93M | 1.93M | 67.59M | 67.59M |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 1.15M | 1.07M | 5.26M | 5.07M | 320.33M |
Long-Term Investments | 0 | 0 | 0 | 0 | 56.62M | 1.96M | 7.16M | 5.48M | 5.01M | 54.97M |
Other Non-Current Assets | 437K | 249K | 6.19M | 3.27M | 8.44M | 9.72M | 7.43M | 27.49M | 340.5M | 10.72M |
Total Assets | 84.58M▲ 0% | 107.7M▲ 27.3% | 93.72M▼ 13.0% | 108.61M▲ 15.9% | 321.16M▲ 195.7% | 295.28M▼ 8.1% | 475.2M▲ 60.9% | 393.84M▼ 17.1% | 792.18M▲ 101.1% | 744.4M▲ 0% |
Asset Turnover | 0.14x | 0.26x | 0.67x | 0.60x | 0.23x | 0.34x | 0.42x | 0.72x | 0.44x | 0.59x |
Asset Growth % | -21% | 27.35% | -12.98% | 15.88% | 195.71% | -8.06% | 60.93% | -17.12% | 101.14% | 181.96% |
Total Current Liabilities | 87.6M | 75.24M | 65.62M | 73.7M | 48.35M | 67.3M | 104.13M | 81.84M | 171.03M | 134.56M |
Accounts Payable | 6.98M | 5.38M | 4.79M | 5.58M | 6.96M | 11.05M | 9.58M | 6.79M | 9.03M | 16.14M |
Days Payables Outstanding | 147.97 | 95.87 | 62.47 | 82.68 | 65.34 | 70.16 | 55.71 | 32.36 | 53.91 | 44.93 |
Short-Term Debt | 52.74M | 11.3M | 5.03M | 4.06M | 6.98M | 9.56M | 20M | 0 | 49.24M | 12.88M |
Deferred Revenue (Current) | 3.04M | 50.87M | 32.5M | 33.27M | 827K | 1.73M | 9.09M | 12.41M | 15.33M | 47.93M |
Other Current Liabilities | 12.97M | 46.76M | 10.13M | 13.46M | 9.53M | 16.43M | 30.97M | 30.37M | 97.43M | 64.98M |
Current Ratio | 0.65x | 1.09x | 0.93x | 1.08x | 4.54x | 3.49x | 3.59x | 3.28x | 1.70x | 1.87x |
Quick Ratio | 0.62x | 1.04x | 0.86x | 1.01x | 4.39x | 3.17x | 3.31x | 2.94x | 1.50x | 1.50x |
Cash Conversion Cycle | -5 | 20.87 | 12.07 | 14.61 | 24.77 | 129.52 | 137.61 | 115.6 | 196.96 | 130.92 |
Total Non-Current Liabilities | 211.71M | 207.55M | 218.63M | 215.32M | 482.16M | 478.52M | 617.24M | 390.82M | 672.17M | 669.04M |
Long-Term Debt | 104.08M | 91.19M | 113.87M | 118.17M | 281.2M | 273.49M | 248.7M | 36.05M | 320.36M | 320.73M |
Capital Lease Obligations | 0 | 0 | 2.51M | 1.2M | 1.04M | 5.34M | 3.92M | 11.64M | 103.78M | 321.07M |
Deferred Tax Liabilities | -500K | -10.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 107.63M | 105.68M | 93.9M | 94.28M | 175.43M | 162.01M | 294.82M | 291.97M | 208.05M | 206.34M |
Total Liabilities | 299.31M | 282.79M | 284.25M | 289.03M | 530.51M | 545.82M | 721.37M | 472.66M | 843.2M | 803.6M |
Total Debt | 156.82M | 102.49M | 121.41M | 123.44M | 289.22M | 288.4M | 272.62M | 47.7M | 473.38M | 436.67M |
Net Debt | 112.88M | 31.33M | 91.51M | 56.43M | 165.03M | 218.63M | 34.14M | 1.36M | 398.5M | 383.84M |
Debt / Equity | - | - | - | - | - | - | - | - | - | -7.38x |
Debt / EBITDA | - | - | - | - | - | - | 20.63x | 0.58x | 9.27x | 14.35x |
Net Debt / EBITDA | - | - | - | - | - | - | 2.58x | 0.02x | 7.80x | 12.62x |
Interest Coverage | -7.83x | -8.19x | -3.76x | -5.07x | -3.88x | -2.53x | 0.42x | 1.80x | 1.10x | 0.29x |
Total Equity | -214.73M▲ 0% | -175.08M▲ 18.5% | -190.53M▼ 8.8% | -180.42M▲ 5.3% | -209.35M▼ 16.0% | -250.54M▼ 19.7% | -246.17M▲ 1.7% | -78.82M▲ 68.0% | -51.02M▲ 35.3% | -59.2M▲ 0% |
Equity Growth % | -16.96% | 18.46% | -8.82% | 5.3% | -16.03% | -19.67% | 1.74% | 67.98% | 35.26% | 188.68% |
Book Value per Share | -2.06 | -1.21 | -0.97 | -0.81 | -0.84 | -0.97 | -0.92 | -0.28 | -0.16 | -0.19 |
Total Shareholders' Equity | -214.73M | -175.08M | -190.53M | -180.42M | -209.35M | -250.54M | -246.17M | -78.82M | -51.02M | -59.2M |
Common Stock | 1.19M | 1.87M | 2.12M | 2.42M | 2.52M | 2.64M | 2.7M | 3.03M | 3.08M | 3.09M |
Retained Earnings | -2.85B | -2.94B | -2.99B | -3.05B | -3.13B | -3.22B | -3.23B | -3.2B | -3.2B | -3.21B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -18K | -19K | -19K | 0 | 0 | 0 | 0 | 1.11M | 115K | -4K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MNKD Cash Flow Statement
MannKind Corporation (MNKD) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -64.78M | -37.73M | -88.48M | -28.13M | -61.71M | -80.7M | 34.09M | 42.51M | 18.25M | 18.83M |
Operating CF Margin % | -551.54% | -135.44% | -140.36% | -43.18% | -81.8% | -80.88% | 17.14% | 14.89% | 5.23% | - |
Operating CF Growth % | 17.05% | 41.75% | -134.51% | 68.21% | -119.39% | -30.77% | 142.25% | 24.69% | -57.06% | 161.55% |
Net Income | -117.33M | -86.97M | -51.9M | -57.24M | -80.93M | -87.4M | -11.94M | 27.59M | 5.86M | -23.91M |
Depreciation & Amortization | 3.53M | 1.7M | 2.15M | 3.33M | 5.47M | 6.29M | 5.8M | 9.04M | 12.28M | 15.97M |
Stock-Based Compensation | 4.85M | 6.86M | 6.2M | 6.51M | 12.2M | 0 | 17.65M | 21.36M | 24.2M | 14.49M |
Deferred Taxes | 12.94M | 0 | -4.57M | 10.65M | 12.64M | 0 | 0 | 0 | -4.97M | -4.97M |
Other Non-Cash Items | 3.67M | 5.71M | -28M | 18.4M | 6.63M | 24.47M | 7.96M | 21M | 67.23M | 106.69M |
Working Capital Changes | 27.57M | 36.68M | -12.36M | -9.78M | -17.73M | -24.05M | 14.63M | -36.47M | -86.35M | -89.43M |
Change in Receivables | -2.49M | -1.34M | 504K | -705K | -776K | -11.81M | 2.35M | 2.65M | -4.76M | 22.62M |
Change in Inventory | -3.3M | -3.15M | -558K | -1.31M | -4.08M | -5.67M | 4.57M | -3.2M | 10.4M | -31.47M |
Change in Payables | 3.8M | -1.6M | -593K | 793K | 1.37M | 4.1M | -1.47M | -2.79M | -16.71M | -7.85M |
Cash from Investing | 16.68M | -234K | -22.84M | 15.22M | -151.54M | 4.87M | -1.99M | -96.65M | -304.8M | -292.04M |
Capital Expenditures | 0 | -354K | -2.56M | -4.78M | -11.47M | -7.59M | -42.44M | -9.69M | -4.57M | -6.12M |
CapEx % of Revenue | - | 1.27% | 4.07% | 7.34% | 15.2% | 7.61% | 21.33% | 3.4% | 1.31% | 1.7% |
Acquisitions | 24K | 120K | 0 | -3.98M | -56.06M | -15.34M | 0 | 0 | -347.74M | -347.74M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 16.68M | 120K | -300K | 20M | 56.06M | 32.8M | 382K | 128.71M | -16.41M | -10M |
Cash from Financing | 73.56M | 61.29M | 69.86M | 49.85M | 270.27M | 21.41M | 136.61M | -137.27M | 315.1M | 278.74M |
Debt Issued (Net) | 15.43M | -5M | 63.7M | 14.87M | 281.08M | -1.09M | -6.86M | -133.17M | 0 | 38.79M |
Equity Issued (Net) | 58.25M | 70.52M | 3.2M | 23.66M | 1.89M | 22.56M | 6.89M | -6.09M | -3.26M | 7.57M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -120K | -4.22M | 2.97M | 11.31M | -12.7M | -62K | 136.58M | 1.99M | 318.36M | 232.38M |
Net Change in Cash | 25.46M▲ 0% | 23.33M▼ 8.4% | -41.46M▼ 277.7% | 36.94M▲ 189.1% | 57.02M▲ 54.4% | -54.42M▼ 195.4% | 168.71M▲ 410.0% | -191.4M▼ 213.4% | 28.55M▲ 114.9% | 5.53M▲ 0% |
Free Cash Flow | -64.78M▲ 0% | -38.09M▲ 41.2% | -91.05M▼ 139.1% | -32.91M▲ 63.9% | -73.17M▼ 122.3% | -88.29M▼ 20.7% | -8.35M▲ 90.5% | 32.82M▲ 493.2% | 13.69M▼ 58.3% | 12.72M▲ 0% |
FCF Margin % | -551.54% | -136.71% | -144.43% | -50.52% | -97% | -88.49% | -4.2% | 11.49% | 3.92% | 3.53% |
FCF Growth % | 18.24% | 41.21% | -139.07% | 63.85% | -122.34% | -20.65% | 90.55% | 493.17% | -58.29% | -41.7% |
FCF per Share | -0.62 | -0.26 | -0.47 | -0.15 | -0.29 | -0.34 | -0.03 | 0.12 | 0.04 | 0.04 |
FCF Conversion (FCF/Net Income) | 0.55x | 0.43x | 1.70x | 0.49x | 0.76x | 0.92x | -2.86x | 1.54x | 3.11x | -0.53x |
Interest Paid | 7.73M | 3.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.56M |
Taxes Paid | 51K | 240K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 869K |
MNKD Key Ratios
MannKind Corporation (MNKD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | - | - | - | - | - | - | 45.59% |
Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | - | 21.55% | 6.08% |
Gross Margin | -46.68% | 26.49% | 55.62% | 62.17% | 48.49% | 42.37% | 68.45% | 73.17% | 82.47% | 75.96% |
Net Margin | -999% | -312.2% | -82.34% | -87.87% | -107.27% | -87.6% | -6% | 9.66% | 1.68% | -6.63% |
Debt / Equity | - | - | - | - | - | - | - | - | - | -7.38x |
Interest Coverage | -7.83x | -8.19x | -3.76x | -5.07x | -3.88x | -2.53x | 0.42x | 1.80x | 1.10x | 0.29x |
FCF Conversion | 0.55x | 0.43x | 1.70x | 0.49x | 0.76x | 0.92x | -2.86x | 1.54x | 3.11x | -0.53x |
Revenue Growth | -93.28% | 137.2% | 126.28% | 3.34% | 15.81% | 32.25% | 99.42% | 43.5% | 22.23% | 21.23% |
Related:MNKD Dividend History·MNKD Revenue History·MNKD Price History·MNKD P/E History·MNKD Financial Ratios·MNKD Institutional Holders
MNKD SEC Filings & Documents
MannKind Corporation (MNKD) SEC filings — annual & quarterly reports (10-K, 10-Q)
MNKD Frequently Asked Questions
MannKind Corporation (MNKD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
MannKind Corporation (MNKD) reported $360.8M in revenue for fiscal year 2025.
MannKind Corporation (MNKD) grew revenue by 22.2% over the past year. This is strong growth.
MannKind Corporation (MNKD) reported a net loss of $23.9M for fiscal year 2025.
Dividend & Returns
MannKind Corporation (MNKD) generated $12.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.